Jim Delshad

Jim Delshad is a declared insider at 2 companies; the most frequent names are Neonc Technologies Holdings, Inc. and Bone Biologics Corp. The record holds 6 filings, for trades running from 19 September 2015 to 12 May 2025.

No open-market sale appears; the market trades are 3 purchases worth €34k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants. 2025 to date brings 3 purchases and no sales.

Half of the purchases are above €744 and half below. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -25.9%. Past outcomes like these are no guarantee of what comes next.

On 19 May 2025 came the latest disclosure, an open-market purchase for €304 in Neonc Technologies Holdings, Inc. Typically, a trade is published a median of 20 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.